The prognostic value of CSF neurofilaments in multiple sclerosis at 15-year follow-up

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 12, 2015, Pages 1388-1390

  Petzold, Axel ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFILAMENT PROTEIN; BIOLOGICAL MARKER;

ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; EXPANDED DISABILITY STATUS SCALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; CEREBROSPINAL FLUID; DISEASE COURSE; NERVE DEGENERATION; PATHOLOGY; PREDICTIVE VALUE; PYRAMIDAL TRACT;

BIOMARKERS; COHORT STUDIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROFILAMENT PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PYRAMIDAL TRACTS;

EID: 84958690650     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-309827     Document Type: Article

References (8)

1. Comabella M, Montalban X. Body fluid biomarkers in multiple sclerosis. Lancet Neurol 2014;13:113-26.
2. Friese MA, Schattling B, Fugger L. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 2014;10:225-38.
3. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 2005;233:183-98.
4. Gresle MM, Butzkueven H, Shaw G. Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis. Mult Scler Int 2011;2011:315406.
5. Dujmovic I. Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis. Mult Scler Int 2011;2011:767083.
6. Petzold A, Eikelenboom M, Gveric D, et al. Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations. Brain 2002;125:1462-73.
7. Petzold A, Eikelenboom MJ, Keir G, et al. Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J Neurol Neurosurg Psychiatry 2005;76:206-11.
8. Petzold A, Tozer DJ, Schmierer K. Axonal damage in the making: neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter. Exp Neurol 2011;232:234-9.